Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$9.93
-4.06%
Mkt Cap $313.51M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (16 analysts)
$30.50
Range $20.00 – $41.00
Implied Upside
+207.2%
Consensus $30.50 vs current $9.93